Improving hospital arrival times for AIS in patients with T2D is cost-effective, but primary prevention yields greater benefits.

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers ...

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

The FDA granted Priority Review to the novel Factor XIa inhibitor asundexian for secondary stroke prevention following an ischemic stroke.

Researchers evaluated the effects of vitamin E supplementation on lipid profiles and body mass index in adults with steatotic liver disease.

The FDA approved the aldosterone synthase inhibitor Baxfendy (baxdrostat) for adults with inadequately controlled hypertension.

A single-shot nanosecond pulsed field ablation catheter safely achieves high rates of acute and durable pulmonary vein isolation in PAF.

Post-stroke employment rates are significantly lower for Black survivors than White survivors despite adjustments for baseline health.

Aerobic and resistance training combined and high-intensity interval training are associated with significant reductions in BP over 24 hours.

Adults with poor mental health report worse self-rated overall health and more chronic illness, according to a study.

After months of pressure from the Trump administration, US Food and Drug Administration (FDA) Commissioner Dr. Marty Makary has quit.

A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis.